The natural history of nonalcoholic fatty liver disease: a population-based cohort study - PubMed (original) (raw)
The natural history of nonalcoholic fatty liver disease: a population-based cohort study
Leon A Adams et al. Gastroenterology. 2005 Jul.
Abstract
Background & aims: The natural history of nonalcoholic fatty liver disease (NAFLD) in the community remains unknown. We sought to determine survival and liver-related morbidity among community-based NAFLD patients.
Methods: Four hundred twenty patients diagnosed with NAFLD in Olmsted County, Minnesota, between 1980 and 2000 were identified using the resources of the Rochester Epidemiology Project. Medical records were reviewed to confirm diagnosis and determine outcomes up to 2003. Overall survival was compared with the general Minnesota population of the same age and sex.
Results: Mean (SD) age at diagnosis was 49 (15) years; 231 (49%) were male. Mean follow-up was 7.6 (4.0) years (range, 0.1-23.5) culminating in 3192 person-years follow-up. Overall, 53 of 420 (12.6%) patients died. Survival was lower than the expected survival for the general population (standardized mortality ratio, 1.34; 95% CI, 1.003-1.76; P = .03). Higher mortality was associated with age (hazard ratio per decade, 2.2; 95% CI, 1.7-2.7), impaired fasting glucose (hazard ratio, 2.6; 95% CI, 1.3-5.2), and cirrhosis (hazard ratio, 3.1, 95% CI, 1.2-7.8). Liver disease was the third leading cause of death (as compared with the thirteenth leading cause of death in the general Minnesota population), occurring in 7 (1.7%) subjects. Twenty-one (5%) patients were diagnosed with cirrhosis, and 13 (3.1%) developed liver-related complications, including 1 requiring transplantation and 2 developing hepatocellular carcinoma.
Conclusions: Mortality among community-diagnosed NAFLD patients is higher than the general population and is associated with older age, impaired fasting glucose, and cirrhosis. Liver-related death is a leading cause of mortality, although the absolute risk is low.
Comment in
- Natural history of NAFLD: remarkably benign in the absence of cirrhosis.
Day CP. Day CP. Gastroenterology. 2005 Jul;129(1):375-8. doi: 10.1053/j.gastro.2005.05.041. Gastroenterology. 2005. PMID: 16012969 Review. No abstract available. - The natural history of NAFLD: impressively unimpressive.
Ioannou GN. Ioannou GN. Gastroenterology. 2005 Nov;129(5):1805. doi: 10.1053/j.gastro.2005.09.041. Gastroenterology. 2005. PMID: 16285987 No abstract available. - Are we overestimating the risks of NASH?
Thomas V, Harish K. Thomas V, et al. Gastroenterology. 2006 Mar;130(3):1015-6; author reply 1016-7. doi: 10.1053/j.gastro.2006.01.078. Gastroenterology. 2006. PMID: 16530550 No abstract available. - Age, impaired fasting glucose, and cirrhosis predicted mortality at mean 7.6 years for non-alcoholic fatty liver disease.
Reichen J. Reichen J. Evid Based Med. 2006 Feb;11(1):26. doi: 10.1136/ebm.11.1.26. Evid Based Med. 2006. PMID: 17213068 No abstract available.
Similar articles
- Nonalcoholic fatty liver disease increases risk of death among patients with diabetes: a community-based cohort study.
Adams LA, Harmsen S, St Sauver JL, Charatcharoenwitthaya P, Enders FB, Therneau T, Angulo P. Adams LA, et al. Am J Gastroenterol. 2010 Jul;105(7):1567-73. doi: 10.1038/ajg.2010.18. Epub 2010 Feb 9. Am J Gastroenterol. 2010. PMID: 20145609 Free PMC article. - NAFLD fibrosis score: a prognostic predictor for mortality and liver complications among NAFLD patients.
Treeprasertsuk S, Björnsson E, Enders F, Suwanwalaikorn S, Lindor KD. Treeprasertsuk S, et al. World J Gastroenterol. 2013 Feb 28;19(8):1219-29. doi: 10.3748/wjg.v19.i8.1219. World J Gastroenterol. 2013. PMID: 23482703 Free PMC article. - The natural history of nonalcoholic fatty liver disease with advanced fibrosis or cirrhosis: an international collaborative study.
Bhala N, Angulo P, van der Poorten D, Lee E, Hui JM, Saracco G, Adams LA, Charatcharoenwitthaya P, Topping JH, Bugianesi E, Day CP, George J. Bhala N, et al. Hepatology. 2011 Oct;54(4):1208-16. doi: 10.1002/hep.24491. Epub 2011 Aug 9. Hepatology. 2011. PMID: 21688282 Free PMC article. - Hepatic, cardiovascular, and endocrine outcomes of the histological subphenotypes of nonalcoholic fatty liver disease.
Rubinstein E, Lavine JE, Schwimmer JB. Rubinstein E, et al. Semin Liver Dis. 2008 Nov;28(4):380-5. doi: 10.1055/s-0028-1091982. Epub 2008 Oct 27. Semin Liver Dis. 2008. PMID: 18956294 Review. - Nonalcoholic fatty liver disease: a systematic review.
Rinella ME. Rinella ME. JAMA. 2015 Jun 9;313(22):2263-73. doi: 10.1001/jama.2015.5370. JAMA. 2015. PMID: 26057287 Review.
Cited by
- Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis.
Anstee QM, Targher G, Day CP. Anstee QM, et al. Nat Rev Gastroenterol Hepatol. 2013 Jun;10(6):330-44. doi: 10.1038/nrgastro.2013.41. Epub 2013 Mar 19. Nat Rev Gastroenterol Hepatol. 2013. PMID: 23507799 Review. - Pathophysiological analysis of nonalcoholic fatty liver disease by evaluation of fatty liver changes and blood flow using xenon computed tomography: can early-stage nonalcoholic steatohepatitis be distinguished from simple steatosis?
Shigefuku R, Takahashi H, Kobayashi M, Ikeda H, Matsunaga K, Okuse C, Matsumoto N, Maeyama S, Sase S, Suzuki M, Itoh F. Shigefuku R, et al. J Gastroenterol. 2012 Nov;47(11):1238-47. doi: 10.1007/s00535-012-0581-4. Epub 2012 May 11. J Gastroenterol. 2012. PMID: 22576023 Clinical Trial. - Pharmacological agents for nonalcoholic steatohepatitis.
Guillaume M, Ratziu V. Guillaume M, et al. Hepatol Int. 2013 Dec;7 Suppl 2:833-41. doi: 10.1007/s12072-013-9482-8. Epub 2013 Nov 19. Hepatol Int. 2013. PMID: 26202298 - The association of genetic polymorphisms with nonalcoholic fatty liver disease in a longitudinal study.
Chung GE, Shin E, Kwak MS, In Yang J, Lee JE, Choe EK, Yim JY. Chung GE, et al. BMC Gastroenterol. 2020 Oct 15;20(1):344. doi: 10.1186/s12876-020-01469-8. BMC Gastroenterol. 2020. PMID: 33059586 Free PMC article. - NAFLD as a risk factor for HCC: new rules of engagement?
Masuzaki R, Karp SJ, Omata M. Masuzaki R, et al. Hepatol Int. 2016 Jul;10(4):533-4. doi: 10.1007/s12072-016-9731-8. Epub 2016 May 5. Hepatol Int. 2016. PMID: 27146835 Free PMC article. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources